Our modular and proven platform technologies guarantee that Ypsomed injection systems are rapidly available for clinical studies and market introduction. Innovative and patented technologies provide our customers with user-friendly injection systems which stand out successfully in the market. All our products are characterised by reliable and tried and tested technical concepts, which are optimised for high volume automated manufacturing.
With over 35 years’ experience, Ypsomed is the global leader in the development of innovative injection systems. We offer this experience to our pharma clients together with comprehensive services tailored to their requirements. We evaluate user needs with our own company experts and with independent market researchers. Efficient manufacturing concepts are considered during the design phase of each new injection system platform.
Ypsomed has developed the world’s first zero carbon emission prefilled autoinjector. The YpsoMate Zero is based on the proven YpsoMate autoinjector platform that offers convenient handling and patient safety.
We provide pharmaceutical companies with integrated digital solutions by combining connected injection devices with digital patient solutions. Ypsomed Digital Health helps facilitate therapy management for patients and generates business-changing insights for pharmaceutical companies.
